n-methyl-3,4-methylenedioxyamphetamine has been researched along with Child Mental Disorders in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " One of such drugs is MDMA (3,4-methylenedioxymethamphetamine) or ecstasy due to its high consumption in relevant age and sex groups and its adverse effects on human and rodent developing brains." | 2.66 | Developmental neurotoxicity of MDMA. A systematic literature review summarized in a putative adverse outcome pathway. ( Barenys, M; Fritsche, E; Gómez-Catalán, J; Masjosthusmann, S; Reverte, I, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barenys, M | 1 |
| Reverte, I | 1 |
| Masjosthusmann, S | 1 |
| Gómez-Catalán, J | 1 |
| Fritsche, E | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Child Mental Disorders
| Article | Year |
|---|---|
Developmental neurotoxicity of MDMA. A systematic literature review summarized in a putative adverse outcome pathway.
Topics: Adverse Outcome Pathways; Animals; Brain; Female; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Ne | 2020 |